Nancy Lin is an Oncology physician. ClinicalTrials.gov lists 15 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
44 Binney St
Dana-Farber Cancer Institute
Boston, MA 021156013
Telephone
617-632-3800Registry record last updated 14 Aug 2007.
Clinical trials
- The SAPPHO Study: Sequential Therapy With Curative Intent in de Novo HER2+ Metastatic Breast Cancer
Sponsor: Dana-Farber Cancer Institute
- DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
Sponsor: Nancy Lin, MD
- STOP-HER2: Stopping Trastuzumab in HER2+ MBC
Sponsor: Dana-Farber Cancer Institute
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year20253 payments
- Stemline Therapeutics Inc.Program year20251 payment
- PFIZER INC.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2019–2025 per NIH RePORTER. The latest:
- Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer
Dana-Farber Cancer Inst
FY2025$2,607,297P50CA168504 - Project 2: Rational approaches to improve treatment outcomes of patients with breast cancer brain metastases
Dana-Farber Cancer Inst
FY2025$277,223P50CA168504 - Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
Dana-Farber Cancer Inst
FY2023$2,302,230P50CA168504
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”